Percutaneous revascularization of chronic coronary occlusions: an overview
JA Puma,
MH Sketch Jr,
JE Tcheng,
RA Harrington,
HR Phillips,
RS Stack,
and
RM Califf
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Patients with a chronic coronary occlusion often undergo coronary angiography after weeks to months of occlusion. The published reports underestimate the extent of this problem because such patients are often arbitrarily assigned to receive medical therapy or undergo bypass surgery as a result of poor success with percutaneous revascularization and substantial restenosis. Thus, there is controversy about the role of angioplasty in this patient cohort. The goal of this overview was to evaluate the available information about angioplasty in chronic coronary occlusions. The primary indication for attempted recanalization of a chronic coronary occlusion has been symptomatic angina pectoris. Anginal status often improves after successful procedures (70% vs. 31% with a failed procedure); left ventricular function may improve; and subsequent referral for coronary artery bypass graft surgery is uncommon (3% vs. 28% in unsuccessful cases). Successful recanalization is achieved in approximately 65% of attempted procedures. Inability to cross the stenosis with a guide wire is the most common cause of procedural failure. Statistically significant predictors of procedural success include older occlusions (75% < 3 months old vs. 37% > or = 3 months old), absence of any anterograde flow through the occlusion (76% with vs. 58% without), angiographically abrupt-appearing occlusions (50% vs. 77% with tapered occlusions), presence of bridging collateral vessels (23% with vs. 71% without) and lesions > 15 mm. Procedural complications occur at a slightly lower incidence than in angioplasty of high grade subtotal stenoses. Long-term success is limited, and restenosis can be expected in > 50% of the patients. The experience with chronic total occlusions of saphenous vein bypass grafts is small, but there appear to be limited procedural success and significant procedural complications, particularly associated with distal emboli. The role of new pharmacologic agents has yet to be defined and that of new devices has been disappointing so far, but further technologic advances are on the horizon.
This article has been cited by other articles:

|
 |

|
 |
 
R. Jaffe, G. Leung, N. R. Munce, A. S. Thind, H. Leong-Poi, K. J.T. Anderson, X. Qi, J. Trogadis, A. Nadler, D. Shiff, et al.
Natural History of Experimental Arterial Chronic Total Occlusions.
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1148 - 1158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M Safley, J. A House, B. D Rutherford, and S. P Marso
Success rates of percutaneous coronary intervention of chronic total occlusions and long-term survival in patients with diabetes mellitus
Diabetes and Vascular Disease Research,
May 1, 2006;
3(1):
45 - 51.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K D Dawkins, T Gershlick, M de Belder, A Chauhan, G Venn, P Schofield, D Smith, J Watkins, H H Gray, and Joint Working Group on Percutaneous Coronary Inter
Percutaneous coronary intervention: recommendations for good practice and training
Heart,
December 1, 2005;
91(suppl_6):
vi1 - vi27.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Fang, Y. T. F. N. Jao, Y. Chen, and S.-P. Wang
Coronary Stenting or Balloon Angioplasty for Chronic Total Coronary Occlusions: The Taiwan Experience (A Single-Center Report)
Angiology,
September 1, 2005;
56(5):
525 - 537.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S Aziz and D R Ramsdale
Chronic total occlusions--a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel?
Heart,
June 1, 2005;
91(suppl_3):
iii42 - iii48.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hoye, K. Tanabe, P. A. Lemos, J. Aoki, F. Saia, C. Arampatzis, M. Degertekin, S. H. Hofma, G. Sianos, E. McFadden, et al.
Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
J. Am. Coll. Cardiol.,
June 2, 2004;
43(11):
1954 - 1958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Strauss, L. Goldman, B. Qiang, N. Nili, A. Segev, J. Butany, J. D. Sparkes, Z. S. Jackson, M. R. Eskandarian, and R. Virmani
Collagenase Plaque Digestion for Facilitating Guide Wire Crossing in Chronic Total Occlusions
Circulation,
September 9, 2003;
108(10):
1259 - 1262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Garcia and J. P. Carrozza Jr
Stenting chroniccoronary artery occlusions: One step closer?
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1493 - 1495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Stone, P. S. Teirstein, R. Rubenstein, D. Schmidt, P. L. Whitlow, E. J. Kosinski, G. Mishkel, and J. A. Power
A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions
J. Am. Coll. Cardiol.,
May 15, 2002;
39(10):
1581 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Suero, S. P. Marso, P. G. Jones, S. B. Laster, K. C. Huber, L. V. Giorgi, W. L. Johnson, and B. D. Rutherford
Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience
J. Am. Coll. Cardiol.,
August 1, 2001;
38(2):
409 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.W Serruys, J.N Hamburger, J Fajadet, M Haude, H Klues, R Seabra-Gomes, T Corcos, C Hamm, L Pizzuli, B Meier, et al.
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial
Eur. Heart J.,
November 1, 2000;
21(21):
1797 - 1805.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mauser
Acute Success Rates of Percutaneous Transluminal Coronary Angioplasty in the Treatment of Chronic Complete Occlusions with Use of the 0.014 Magnum Meier Wire
Angiology,
October 1, 2000;
51(10):
849 - 854.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schofer, T. Rau, M. Schluter, and D.G. Mathey
Restenosis after stenting of matched occluded and non-occluded coronary arteries. Should there be a difference?
Eur. Heart J.,
August 2, 1999;
20(16):
1175 - 1181.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Sirnes, S. Golf, Y. Myreng, P. Molstad, P. Albertsson, A. Mangschau, K. Endresen, and J. Kjekshus
Sustained benefit of stenting chronic coronary occlusion: long-term clinical follow-up of the Stenting in Chronic Coronary Occlusion (SICCO) study
J. Am. Coll. Cardiol.,
August 1, 1998;
32(2):
305 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rubartelli, L. Niccoli, E. Verna, C. Giachero, M. Zimarino, A. Fontanelli, C. Vassanelli, L. Campolo, E. Martuscelli, G. Tommasini, et al.
Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial
J. Am. Coll. Cardiol.,
July 1, 1998;
32(1):
90 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Hancock, M R Thomas, S Holmberg, R J Wainwright, and D E Jewitt
Randomised trial of elective stenting after successful percutaneous transluminal coronary angioplasty of occluded coronary arteries
Heart,
January 1, 1998;
79(1):
18 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Hasdai, P. B. Berger, M. R. Bell, C. S. Rihal, K. N. Garratt, and D. R. Holmes Jr
The Changing Face of Coronary Interventional Practice: The Mayo Clinic Experience
Arch Intern Med,
March 24, 1997;
157(6):
677 - 682.
[Abstract]
[PDF]
|
 |
|
|